Brief: WPD Pharmaceuticals Partners With CNS Pharmaceuticals On Drug Development For Coronavirus And Other Antiviral Indications
24/03/2020 08:43
March 24 (Reuters) - WPD Pharmaceuticals Inc WBIO.CD :
* WPD PHARMACEUTICALS PARTNERS WITH CNS PHARMACEUTICALS ON
DRUG
DEVELOPMENT FOR CORONAVIRUS AND OTHER ANTIVIRAL INDICATIONS
Source text for Eikon: ID:nGNX78l50M
Further company coverage: WBIO.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on WPD Pharmaceuticals
See all newsBrief: Mabion Signs LoI With WPD Pharmaceuticals On Extension Of Cooperation
Brief: Mabion Signs About 2 Mln Zloty Deal With WPD Pharmaceuticals
Brief: WPD Pharmaceuticals Signs Annex To License Agreement With Wake Forest University Health Sciences
Brief: WPD Pharmaceuticals Announces Proposed Restructuring Of Polish Subsidiary
Brief: WPD Pharmaceuticals Enters Into Amended And Restated Sublicense Agreement With Moleculin Biotech